Clinical trial
68Ga-grazytracer PET/CT Study in Inflammatory Bowel Disease
NCT07022080 is registered in ClinicalTrials.gov with Xijing Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- 68Ga-grazytracer PET/CT Study in Inflammatory Bowel Disease
- Lead sponsor
- Xijing Hospital
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- June 15, 2025
- Completion date
- December 31, 2027
- Enrollment
- 69 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
inflammatory bowel diseases (ibd)